DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/hkqfw4/medipoint) has announced the addition of GlobalData's new report "MediPoint: Transcatheter Aortic Valve Replacement - Analysis and Market Forecast - European Markets" to their offering.
This report is a vital source of up-to-date information with in-depth analysis on the rapidly growing Transcatheter Aortic Valve Replacement (TAVR) Device Market in France, Germany, Italy, Spain and the UK (EU). Provided within is a comprehensive breakdown of opportunities and inhibitors within the major EU TAVR markets, highlighting testimonials from top physicians from around the world utilizing this technique already. The report identifies and analyzes the key trends shaping and driving the EU Transcatheter Aortic Valve Replacement Market. Future EU sales expectations are discussed through careful analysis of the Transcatheter Aortic Valve Replacement procedure adoption patterns. The report provides insight into the competitive TAVR landscape in the EU, including new companies entering the market and pipeline products in development. It quantifies the potential of percutaneous valve replacement with inoperable and high-risk surgical candidates currently receiving no treatment as well as examines the impact of this disruptive technology in the EU. Included is the investigation of the highest growth sectors for TAVR, with a focus on the EU.
This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by a team of industry experts.
Scope
- An overview of Aortic Valve Disease, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.
- Annualized EU transcatheter aortic valve market revenue, future forecasts and procedure patterns data (for treating aortic stenosis and aortic regurgitation) from 2009 to 2011, forecast for 7 years to 2018.
- Investigation of current and future market competition for Transcatheter Aortic Valve Replacement, otherwise known as Transcatheter Aortic Valve Implantation, or TAVI.
- Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events.
- Competitor assessment including device approval analysis and device sales forecasts.
- Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast.
- Analysis of unmet needs within the market and opportunities for future players.
- Technology trends evaluation to assess strength of pipeline.
- An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines.
- Company profiles including business description, financial overview and SWOT analysis.
- Coverage of key market players.
- Strategic assessment of the EU device sector through market impact analysis, future market scenario and company analysis.
- Direct quotes from Key Opinion Leaders (KOL) as well as interventional cardiologists and cardiac surgeons already using these novel devices.
Reasons to buy
- Understand the trends shaping and driving the EU Transcatheter Aortic Valve Replacement Market.
- Realize device preferences of physicians who have performed hundreds of replacements already.
- Access market sizing, forecasts and quantified growth opportunities in the EU Transcatheter Aortic Valve Replacement Market through 2018.
- Quantify candidate patient populations to better design product pricing & launch plans.
- Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape.
- Perform benchmarking analysis of growth opportunities against currently marketed products.
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market.
- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth.
- What's the next big thing in the global Transcatheter Aortic Valve Replacement market landscape? Identify, understand and capitalize.
Companies Mentioned
- AorTech International plc
- Boston Scientific
- Bracco SpA
- Braile Biomedica
- Colibri Heart Valve, LLC
- Direct Flow Medical
- Edwards Lifesciences, Inc.
- Hansen Medical
- JenaValve Technology
- Medtronic, Inc.
- Perouse Medical
- St. Jude Medical
- Symetis
- Transcatheter Technologies GmbH
- ValveXchange
For more information visit http://www.researchandmarkets.com/research/hkqfw4/medipoint
Source: GlobalData